This article is more than 5 years old. Information may no longer be current.

VIDEO: Simpler ART therapies needed to close treatment gaps

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — Joseph J. Eron, MD, professor of medicine at the University of North Carolina, summarizes his presentation on the future of ART at the 2016 Conference on Retroviruses and Opportunistic Infections.

Current ART therapies are effective and can suppress viral loads to undetectable levels in 90% of patients receiving treatment, Eron says. Simpler therapies with less toxicity, however, are needed to increase treatment rates in patients with substance abuse, patients with mental illnesses, children and adolescents.

Disclosure: Eron reports being a consultant for Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV Healthcare, and reports institutional grants from AbbVie, Gilead Sciences, Janssen and ViiV Healthcare.